Literature DB >> 33891207

Polymorphisms of vascular endothelial growth factor and recurrent implantation failure: a systematic review and meta-analysis.

Hong Zeng1,2, Lian Hu3, Hebin Xie4, Wenmin Ma5, Song Quan6.   

Abstract

PURPOSE: To investigate the associations between polymorphisms of vascular endothelial growth factor (VEGF) with recurrent implantation failure (RIF).
METHODS: We performed the systematic review and meta-analysis by searching databases of PubMed, EMBASE, OVID, and CNKI (China National Knowledge Infrastructure) for studies that evaluated the associations between VEGF polymorphisms with RIF. Meta-analysis was performed if the polymorphism was studied by more than two case-control studies. Data were analyzed using R software. Odds ratios (ORs) with 95% confidence intervals (CIs) were reported to assess the associations.
RESULTS: Nine VEGF polymorphisms (-1154G > A, -460T > C, +405G > C, -7C > T, -634C > G, -2578C > A, +936C > T, 5C > T, -583C > T) were systematically reviewed. Meta-analysis was performed on VEGF -1154 G > A polymorphism. Three case-control studies consisted of 683 women were included in the quantitative meta-analysis (305 RIF patients and 378 controls). Results showed that VEGF -1154A allele was significantly associated with RIF (OR 1.39, 95% CI 1.08-1.78, P-value = 0.01). The dominant genetic model showed that VEGF 1154AA plus VEGF 1154AG genotypes were more frequent in RIF patients than VEGF 1154GG genotype (OR 1.56, 95% CI 1.10-2.20, P-value = 0.01). However, the result under the recessive genetic model showed no significant difference (OR 1.67, 95% CI 0.92-3.03, P-value = 0.09).
CONCLUSION: VEGF -1154A allele may serve as one of the predisposing factors of RIF. Women with VEGF 1154 AA/GA genotypes were at higher risk of RIF. However, we should consider the haplotype effect of VEGF polymorphisms in future studies.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Genetic polymorphism; Meta-analysis; Recurrent implantation failure; Systematic review; Vascular endothelial growth factor

Year:  2021        PMID: 33891207     DOI: 10.1007/s00404-021-06072-0

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  85 in total

Review 1.  Recurrent implantation failure: definition and management.

Authors:  C Coughlan; W Ledger; Q Wang; Fenghua Liu; Aygul Demirol; Timur Gurgan; R Cutting; K Ong; H Sallam; T C Li
Journal:  Reprod Biomed Online       Date:  2013-09-14       Impact factor: 3.828

Review 2.  Maternal nutrition influences angiogenesis in the placenta through peroxisome proliferator activated receptors: A novel hypothesis.

Authors:  Akshaya Meher; Deepali Sundrani; Sadhana Joshi
Journal:  Mol Reprod Dev       Date:  2015-07-06       Impact factor: 2.609

Review 3.  What exactly do we mean by 'recurrent implantation failure'? A systematic review and opinion.

Authors:  Lukasz T Polanski; Miriam N Baumgarten; Siobhan Quenby; Jan Brosens; Bruce K Campbell; Nicholas J Raine-Fenning
Journal:  Reprod Biomed Online       Date:  2014-01-17       Impact factor: 3.828

4.  Association between estrogen receptor 1 (ESR1) and leukemia inhibitory factor (LIF) polymorphisms can help in the prediction of recurrent implantation failure.

Authors:  Laura Diniz Vagnini; Adriana Renzi; Bruna Petersen; Maria do Carmo Tomitão Canas; Claudia Guilhermino Petersen; Ana Lucia Mauri; Mariana Coltri Mattila; Juliana Ricci; Felipe Dieamant; João Batista Alcantara Oliveira; Ricardo Luiz Razera Baruffi; José Gonçalves Franco
Journal:  Fertil Steril       Date:  2019-01-02       Impact factor: 7.329

5.  Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos.

Authors:  Sachie Hiratsuka; Yuki Kataoka; Kazuki Nakao; Kenji Nakamura; Shunichi Morikawa; Satoshi Tanaka; Motoya Katsuki; Yoshiro Maru; Masabumi Shibuya
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

6.  Association of angiogenic cytokines (VEGF-A and VEGF-C) and clinical characteristic in women with unexplained recurrent miscarriage.

Authors:  A Bagheri; P Kumar; A Kamath; P Rao
Journal:  Bratisl Lek Listy       Date:  2017       Impact factor: 1.278

Review 7.  Vascular endothelial growth factor as a target for anticancer therapy.

Authors:  Napoleone Ferrara
Journal:  Oncologist       Date:  2004

Review 8.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

Review 9.  The discovery of placenta growth factor and its biological activity.

Authors:  Sandro De Falco
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

10.  Association of Dll4/notch and HIF-1a -VEGF signaling in the angiogenesis of missed abortion.

Authors:  Yan Fang; Shuang Yu; Yuyan Ma; Ping Sun; Daoxin Ma; Chunyan Ji; Beihua Kong
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

View more
  1 in total

1.  Placental diabesity: placental VEGF and CD31 expression according to pregestational BMI and gestational weight gain in women with gestational diabetes.

Authors:  Dario Pitocco; Antonio Lanzone; Angelo Sirico; Esther Diana Rossi; Valentina Anna Degennaro; Vincenzo Arena; Alessandro Rizzi; Linda Tartaglione; Mauro Di Leo
Journal:  Arch Gynecol Obstet       Date:  2022-07-14       Impact factor: 2.493

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.